Artificial Intelligence

MedCity Pivot Podcast: It’s Time To Talk About Responsible AI

A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.

Suchi Saria, CEO of Bayesian Health and Associate Professor of Medicine, Johns Hopkins University

It’s hard to get away from the topic of large language models, chatGPT and more broadly, artificial intelligence in healthcare. It’s all over the news, on social media, in the conferences we go to (including MedCity’s own INVEST conference that concluded earlier this week in Chicago) and even in the pitches that I get from our healthcare content contributors.

Yet the fear about AI is real. And I don’t mean Ex Machina type doomsday scenarios where AI gets sentient and takes over the human world. The more rational fear is its authoritative tone, the ability to present even false information as if it were true — think of deep fakes — not to mention things algorithms being leveraged to deny care.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

In response to the awesome power this new technology wields — that some believe will emerge to be as pivotal as the industrial revolution — there is a greater recognition that standards need to be developed. Not surprisingly, global agencies, corporations have taken up the charge of setting forth guidelines for responsible AI including the White House. In this episode of the Pivot podcast, I spoke with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab. She is also CEO of Bayesian Health. Saria has spent a lot of time researching this topic of responsible AI and how to develop a framework for its adoption in healthcare.